Global Red Biotechnology Market Size & Outlook, 2023-2030
Global red biotechnology market, 2018-2030 (US$M)
Related Markets
Global red biotechnology market highlights
- The global red biotechnology market generated a revenue of USD 492,708.4 million in 2023 and is expected to reach USD 997,744.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 10.6% by 2030.
- In terms of segment, monoclonal antibodies accounted for a revenue of USD 243,959.0 million in 2023.
- Gene Therapy Products is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 492,708.4 million |
| Market revenue in 2030 | USD 997,744.0 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Gene Therapy Products |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products, Gene Therapy Products, Cell Therapy Products, Tissue-Engineered Products, Stem Cells, Cell Culture, Viral Vector, Enzymes, Kits and Reagents, Animal Models, Molecular Diagnostics |
Other key industry trends
- In terms of revenue, the North America accounted for 37.0% of the global red biotechnology market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 1,901.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Red Biotechnology Market Scope
Red Biotechnology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global red biotechnology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to red biotechnology market will help companies and investors design strategic landscapes.
Monoclonal antibodies was the largest segment with a revenue share of 49.51% in 2023. Horizon Databook has segmented the Global red biotechnology market based on monoclonal antibodies, polyclonal antibodies, recombinant proteins, vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, stem cells, cell culture, viral vector, enzymes, kits and reagents, animal models, molecular diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Red Biotechnology Product Outlook (Revenue, USD Million, 2018-2030)
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Proteins
- Vaccines
- Cell-Based Immunotherapy Products
- Gene Therapy Products
- Cell Therapy Products
- Tissue-Engineered Products
- Stem Cells
- Cell Culture
- Viral Vector
- Enzymes
- Kits and Reagents
- Animal Models
- Molecular Diagnostics
- Others
- Global Red Biotechnology End Use Outlook (Revenue, USD Million, 2018-2030)
- Academic Research Institutes
- CMOs & CROs
- Pharmaceutical & Biotechnology Companies
- Others
Reasons to subscribe to Global red biotechnology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global red biotechnology market databook
-
Our clientele includes a mix of red biotechnology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global red biotechnology market , including forecasts for subscribers. This global databook contains high-level insights into Global red biotechnology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global red biotechnology market size, by regions, 2018-2030 (US$M)
Top 10 countries: Red biotechnology market size, 2023 (US$M)
Global red biotechnology market share, by product, 2023 & 2030 (%, US$M)
Red biotechnology market: Opportunity assessment by country
Global red biotechnology market, by region, 2023 (US$M)
| Product | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 112,403.6 | 126,442.2 | 138,430.4 | 193,803.4 | 196,285.0 | 182,176.2 | 195,910.3 | 209,877.9 | 224,219.1 | 238,840.5 | 253,606.3 | 268,370.8 | 282,993.5 | 6.5% |
| Europe | 81,432.5 | 93,662.5 | 104,929.7 | 150,442.4 | 156,170.2 | 148,688.5 | 164,173.2 | 180,746.0 | 198,628.8 | 217,856.1 | 238,425.2 | 260,321.9 | 283,532.3 | 9.7% |
| Asia Pacific | 48,058.5 | 57,707.1 | 67,590.3 | 101,468.0 | 110,459.1 | 110,463.0 | 128,319.1 | 148,882.1 | 172,726.3 | 200,358.9 | 232,336.6 | 269,296.6 | 311,982.2 | 16.0% |
| Latin America | 14,150.6 | 16,582.6 | 18,939.6 | 27,702.2 | 29,356.9 | 28,553.7 | 32,231.1 | 36,303.8 | 40,848.1 | 45,908.3 | 51,525.3 | 57,742.1 | 64,606.6 | 12.4% |
| MEA | 10,946.7 | 12,907.1 | 14,835.7 | 21,842.6 | 23,305.0 | 22,827.0 | 25,954.4 | 29,453.9 | 33,398.3 | 37,837.0 | 42,818.9 | 48,396.5 | 54,629.4 | 13.3% |
| Overall | 266,991.9 | 307,301.6 | 344,725.5 | 495,258.7 | 515,576.3 | 492,708.4 | 546,588.1 | 605,263.7 | 669,820.6 | 740,800.8 | 818,712.2 | 904,127.9 | 997,744.0 | 10.6% |
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
